Shattuck Labs (STTK) Interest Expenses (2019 - 2025)
Shattuck Labs' (STTK) quarterly Interest Expenses came in at $106.7 million in Q4 2025, up 11.57% year-on-year from $95.6 million in Q4 2024, and up 26571.5% on a QoQ basis from $400000.0 in Q3 2025.
Shattuck Labs (STTK) Interest Expenses (2019 - 2025) Analysis & Trends
Shattuck Labs (STTK) has 7 years of Interest Expenses data on file, last reported at $106.7 million in Q4 2025.
- On a quarterly basis, Interest Expenses rose 11.57% year-over-year to $106.7 million in Q4 2025; TTM through Mar 2026 was -$200000.0, a N/A change from a year earlier, with the FY2025 full-year figure at $106.7 million, up 11.57% from the prior year.
- Interest Expenses for Q4 2025 stood at $106.7 million, up from $400000.0 in the prior quarter.
- Over the last five years, Interest Expenses for STTK reached as high as $106.7 million in Q4 2025 and fell as low as -$200000.0 in Q4 2022.
- Historically, Interest Expenses has averaged $21.6 million across 5 years, with a median of $6.4 million in 2022.
- Across the five-year window, Interest Expenses plunged 100.66% in 2022 and jumped 38293.0% in 2023, its largest moves.
- Year by year, Interest Expenses stood at $30.3 million in 2021, then tumbled by 100.66% to -$200000.0 in 2022, then soared by 38293.0% to $76.4 million in 2023, then rose by 25.18% to $95.6 million in 2024, then gained by 11.57% to $106.7 million in 2025.
- Per Business Quant data, the three most recent Interest Expenses figures were $106.7 million in Q4 2025, $400000.0 in Q3 2025, and $100000.0 in Q2 2025.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Int Expense (Qtr) |
|---|---|---|---|---|---|
| 1 | Oculis Holding AG | 67,072.09 Bn | 67,072.09 Bn | - | -42,141.15 |
| 2 | Nanobiotix | 1,894.61 Bn | 1,894.55 Bn | - | - |
| 3 | Akari Therapeutics | 1,014.18 Bn | 1,014.18 Bn | - | 100,000.00 |
| 4 | BeOne Medicines | 471.64 Bn | 466.85 Bn | 1.35 Bn | 32.89 Mn |
| 5 | Vertex Pharmaceuticals | 121.72 Bn | 114.47 Bn | 2.59 Bn | 420.30 Mn |
| 6 | Regeneron Pharmaceuticals | 68.28 Bn | 59.52 Bn | 3.31 Bn | 28.30 Mn |
| 7 | Belite Bio | 61.40 Bn | 61.40 Bn | - | - |
| 8 | Argenx Se | 56.94 Bn | 56.94 Bn | 1.18 Bn | - |
| 9 | Revolution Medicines | 37.37 Bn | 37.37 Bn | - | 1.17 Bn |
| 10 | Shattuck Labs | 831.66 Mn | 831.66 Mn | - | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | 106.69 Mn |
| Dec 31, 2025 | 106.69 Mn |
| Sep 30, 2025 | 400,000.00 |
| Sep 30, 2025 | 400,000.00 |
| Jun 30, 2025 | 100,000.00 |
| Jun 30, 2025 | 100,000.00 |
| Dec 31, 2024 | 95.62 Mn |
| Dec 31, 2024 | 95.62 Mn |
| Sep 30, 2024 | 800,000.00 |
| Sep 30, 2024 | 800,000.00 |
| Jun 30, 2024 | 1.30 Mn |
| Jun 30, 2024 | 1.30 Mn |
| Mar 31, 2024 | 12.40 Mn |
| Mar 31, 2024 | 12.40 Mn |
| Dec 31, 2023 | 76.39 Mn |
| Dec 31, 2023 | 76.39 Mn |
| Sep 30, 2023 | 100,000.00 |
| Sep 30, 2023 | 100,000.00 |
| Jun 30, 2023 | 300,000.00 |
| Jun 30, 2023 | 300,000.00 |